Article
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
2025-01-28
Abstract excerpt
Immune checkpoint inhibition (ICI) has fundamentally changed cancer treatment. However, only a minority of patients with metastatic triple negative breast cancer (TNBC) benefit from ICI, and the determinants of response remain largely unknown. To better understand the factors influencing patient outcome, we assembled a longitudinal cohort with tissue from multiple timepoints, including primary tumor, pre-treatment...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 487e791d-98ee-5bb1-b0ae-7b104e2780cf
- DOI
- 10.1101/2025.01.26.634557
